🇺🇸 Iovance Biotherapeutics, Inc.
Forum topic · IOVA · Company page: financials, ownership and filings
Market value
$4.4 B
Automatic updates
2
Mutual funds 1 · Results 1
Member comments
0
approved by an editor
Reactions
0
Join the discussion on Iovance Biotherapeutics, Inc.
Loading…
Results announced on 5 November 2026
Iovance Biotherapeutics, Inc. announced results on 5 November 2026 (SEC Form 8-K, item 2.02).
For the quarter ended 30 September 2026: revenue of $121 million (up 80% from a year earlier) and a net loss of $22 million.
Mutual funds: 163 funds hold $423 million
163 mutual funds in 1 country hold shares of Iovance Biotherapeutics, Inc. worth $423 million, about 13.2% of the company (funds' newest reports, up to 31 July 2026).
Since their previous reports 108 funds added shares and 38 sold; on balance they bought $67 million. Share splits are not counted as trading.